These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37529952)

  • 41. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.
    Kinoshita Y; Fukumoto S
    Endocr Rev; 2018 Jun; 39(3):274-291. PubMed ID: 29381780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mineralized tissues in hypophosphatemic rickets.
    Robinson ME; AlQuorain H; Murshed M; Rauch F
    Pediatr Nephrol; 2020 Oct; 35(10):1843-1854. PubMed ID: 31392510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Function of PHEX mutations p.Glu145* and p.Trp749Arg in families with X-linked hypophosphatemic rickets by the negative regulation mechanism on FGF23 promoter transcription.
    Gan YM; Zhang YP; Ruan DD; Huang JB; Zhu YB; Lin XF; Xiao XP; Cheng Q; Geng ZB; Liao LS; Tang FQ; Luo JW
    Cell Death Dis; 2022 Jun; 13(6):518. PubMed ID: 35654784
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improvement in the mobility of a patient with fibroblast growth factor 23-related hypophosphatemic osteomalacia and decompensated liver cirrhosis in response to burosumab: a case report.
    Toi N; Imanishi Y; Nagata Y; Kurajoh M; Morioka T; Shoji T; Shinto Y; Emoto M
    Endocr J; 2023 Apr; 70(4):419-426. PubMed ID: 36575021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Novel PHEX Mutation in Japanese Patients with X-Linked Hypophosphatemic Rickets.
    Kawahara T; Watanabe H; Omae R; Yamamoto T; Inazu T
    Case Rep Genet; 2015; 2015():301264. PubMed ID: 25861491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Earlier Onset in Autosomal Dominant Hypophosphatemic Rickets of R179 than R176 Mutations in Fibroblast Growth Factor 23: Report of 20 Chinese Cases and Review of the Literature.
    Liu C; Zhao Z; Wang O; Li M; Xing X; Hsieh E; Fukumoto S; Jiang Y; Xia W
    Calcif Tissue Int; 2019 Nov; 105(5):476-486. PubMed ID: 31486862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism.
    Fukumoto S
    Calcif Tissue Int; 2016 Apr; 98(4):334-40. PubMed ID: 26126937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Bone and Calcium Research Update 2015. Novel treatment for FGF23-related hypophosphatemic diseases].
    Fukumoto S
    Clin Calcium; 2015 Jan; 25(1):37-44. PubMed ID: 25530521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral Iron Replacement Normalizes Fibroblast Growth Factor 23 in Iron-Deficient Patients With Autosomal Dominant Hypophosphatemic Rickets.
    Imel EA; Liu Z; Coffman M; Acton D; Mehta R; Econs MJ
    J Bone Miner Res; 2020 Feb; 35(2):231-238. PubMed ID: 31652009
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phosphatonins: From Discovery to Therapeutics.
    Kritmetapak K; Kumar R
    Endocr Pract; 2023 Jan; 29(1):69-79. PubMed ID: 36210014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A compound heterozygous mutation in SLC34A3 causes hereditary hypophosphatemic rickets with hypercalciuria in a Chinese patient.
    Chi Y; Zhao Z; He X; Sun Y; Jiang Y; Li M; Wang O; Xing X; Sun AY; Zhou X; Meng X; Xia W
    Bone; 2014 Feb; 59():114-21. PubMed ID: 24246249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosis and management of X-linked hypophosphatemia in children and adolescent in the Gulf Cooperation Council countries.
    Al Juraibah F; Al Amiri E; Al Dubayee M; Al Jubeh J; Al Kandari H; Al Sagheir A; Al Shaikh A; Beshyah SA; Deeb A; Habeb A; Mustafa M; Zidan H; Mughal MZ
    Arch Osteoporos; 2021 Mar; 16(1):52. PubMed ID: 33660084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic analysis of three families with X-linked dominant hypophosphatemic rickets.
    Lin X; Zhu Y; Luo J; Huang J
    J Pediatr Endocrinol Metab; 2018 Jul; 31(7):789-797. PubMed ID: 29858904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical aspect of recent progress in phosphate metabolism. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23)].
    Endo I
    Clin Calcium; 2009 Jun; 19(6):815-20. PubMed ID: 19483276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathogenic role of Fgf23 in Dmp1-null mice.
    Liu S; Zhou J; Tang W; Menard R; Feng JQ; Quarles LD
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E254-61. PubMed ID: 18559986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.
    Wolf M; White KE
    Curr Opin Nephrol Hypertens; 2014 Jul; 23(4):411-9. PubMed ID: 24867675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic Causes of Rickets.
    Acar S; Demir K; Shi Y
    J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):88-105. PubMed ID: 29280738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes of the lower limb deformity in children with FGF23-related hypophosphatemic rickets treated with Burosumab: a single-center prospective study.
    Sawamura K; Hamajima T; Izawa M; Kaneko H; Kitamura A; Kitoh H
    J Pediatr Orthop B; 2024 Jan; 33(1):90-96. PubMed ID: 36728857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets.
    Razali NN; Hwu TT; Thilakavathy K
    J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1009-17. PubMed ID: 25894638
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Updates on rickets and osteomalacia: anti-FGF23 antibody, a new therapeutic approach for hypophosphatemic rickets/osteomalacia].
    Shimada T
    Clin Calcium; 2013 Oct; 23(10):1469-75. PubMed ID: 24076645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.